Public Company News

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

SUZHOU, China, March 28, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has completed the enrollment of 740 subjects recently for...

2023-03-28 21:41 2550

Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5.6 Times Year-Over-Year and Accelerated Global Innovation

SHANGHAI and HONG KONG, March 28, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its full-year 2022 financial results and provided updates on key events and achievements since the start of 2022. 1. Sales Revenue Reached 5.6 Times Year-Over-Year ...

2023-03-28 21:40 3524

Antelope Enterprise Holdings Ltd. Regains Compliance with NASDAQ Minimum Bid Price Requirement

CHENGDU, China, March 28, 2023 /PRNewswire/ -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) ("Antelope Enterprise" or the "Company"), the majority owner and operator of KylinCloud, a leading livestreaming social ecommerce platform with 300,000+ anchors and influencers in Ch...

2023-03-28 21:25 3231

Invitation to Autoliv's Q1, 2023 Earnings Call

STOCKHOLM, March 28, 2023 /PRNewswire/ -- Autoliv Inc., plans to publish it´s Financial Report for the first quarter 2023 onFriday, April 21, 2023 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a teleconference will take place the same day. Ti...

2023-03-28 21:05 2262

Global Lifestyle Retailer MINISO Announces New Partnerships and Expansion Plans in Four Markets

GUANGZHOU, China, March 28, 2023 /PRNewswire/ -- Global lifestyle retailer MINISO has announced its plans to expand operations into three new markets, namelyAngola, Trinidad and Tobago, and Latvia. With Panama, the four new partnerships were unveiled during MINISO's Global Partners Summit, hel...

2023-03-28 21:00 3346

NaaS Technology Inc. to Present at Upcoming Investor Conference

BEIJING, March 28, 2023 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) (the "Company"), one of the largest and fastest-growing electric vehicle charging service providers inChina, today announced that the Company's President and Chief Financial Officer, Alex Wu, will present at the following...

2023-03-28 21:00 2377

WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

WUXI, China, March 28, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic partner Amicus Therapeutics ("Amicus") (Nasdaq: FOLD) on receiving European Commission's approval ...

2023-03-28 20:11 3905

IBM Brings Generative AI Commentary and Hole-by-Hole Player Predictions to the Masters Digital Experience

IBM unveils new iteration of its "Let's create" campaign during this year's Masters Tournament, featuring golferKurt Kitayama ARMONK, N.Y., March 28, 2023 /PRNewswire/ -- IBM (NYSE: IBM ) and the Masters Tournament, today introduced two innovative new features as p...

2023-03-28 20:00 3260

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

NANJING, China, March 28, 2023 /PRNewswire/ -- PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CDMO company focusing on innovative chemistry and low-carbon manufacturing, announced today that it has been selected asthe winner of the 2023 CMO Excellence in Green Chemistry Award ...

2023-03-28 20:00 3234

WiMi Hologram Cloud Develops AI Information Management Platform Based on Data Mining Algorithm

BEIJING, March 28, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that to address the limitations of existing tools and products in big data mining, a new artificial in...

2023-03-28 20:00 2522

Sirnaomics Announces 2022 Annual Results

Significant Progress in Clinical Trials for Core Products Reinforces Leading Position in RNA Therapeutics with Strong Product Pipeline Matrix Business Highlights * Clinical development * STP705 -  The part-one Phase IIb interim data on STP705 for the treatment of isSCC was announced, with th...

2023-03-28 19:26 8539

Tigermed Reports Full Year 2022 Results

HANGZHOU, China, March 28, 2023 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its an...

2023-03-28 19:09 3714

Seegene declares to share Syndromic PCR technologies to prevent future pandemics

* Localization of Seegene Syndromic PCR technologies with global partners for versatile and proactive response to local emerging healthcare demands. * Formation of a collaborative global network to aggressively develop innovative syndromic PCR assays, challenging boundaries of PCR application....

2023-03-28 19:00 2919

51Talk Online Education Group to Report Third Quarter, Fourth Quarter and Fiscal Year 2022 Financial Results on Wednesday, March 29, 2023

Earnings Call Scheduled for 8:00 a.m. EST on March 29, 2023 SINGAPORE , March 28, 2023 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE: COE), a global online education platform with core expertise in English education, today announced that it will report its unau...

2023-03-28 18:10 2655

Futu Records US$292.3 Million Total Revenues for Fourth Quarter 2022, a YoY Increase of 42.3%

 Its subsidiary moomoo further diversifies businesses and sharpens long-term globalization strategy in Q4 PALO ALTO, Calif., March 28, 2023 /PRNewswire/ -- Moomoo's parent company Futu Holdings Limited (Nasdaq: FUTU) ("Futu", the "Company"), a leading tech-driven digital brokerage and wealt...

2023-03-28 17:29 4151

Yokogawa Releases OpreX Asset Health Insights with Enhanced Functionality and Alibaba Cloud Support

HONG KONG, March 28, 2023 /PRNewswire/ -- Yokogawa Electric Corporation (TOKYO: 6841) announces the release of OpreX™ Asset Health Insights (2.0), an enhanced version of the company's cloud-based plant asset monitoring service, which is part of the OpreX Asset Management and Integrity family. In ...

2023-03-28 17:21 3326

Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement

Performance Highlights: * During the reporting period, the revenue was RMB 43.952 billion, with a year-on-year growth of12.66%; the net profit after deducting extraordinary gain or loss attributable to owners of the parent wasRMB 3.873 billion, with a year-on-year growth of 18.17%; * The rev...

2023-03-28 16:20 3814

Ragnarok Origin Announces Tesla Giveaway Winner and Major Updates

The Dream Giveaway continues alongside many new exciting updates in March SEOUL, South Korea, March 28, 2023 /PRNewswire/ -- Ragnarok Origin is sending off March with a bang, announcing the winner of the Dream Giveaway Event, as well as announcing major in-game content updates. &am...

2023-03-28 16:00 2762

Ping An Releases 2022 Sustainability Report Reveals Roadmap to Achieve Carbon Neutrality Goal

HONG KONG and SHANGHAI, March 28, 2023 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An" or the "Group", HKEx:2318; SSE:601318) has published its 2022 Sustainability Report. The Group's 14th annual sustainability report includes its 3rd report using the international Task...

2023-03-28 15:42 3656

OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab

SHENZHEN, China, March 28, 2023 /PRNewswire/ -- OncoVent Co., Ltd. ("OncoVent"), a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), yesterday entered into a license agreement with Orient EuroPharma Co., Ltd. ("OEP"). According to the terms of th...

2023-03-28 15:36 2386